Agenda
The following agenda is for the 2025 DRIVE meeting event.
Friday, March 7th, 2025
| Time | Event/Topic |
|---|---|
| 6:30 AM - 7:00 AM | Continental Breakfast |
Precursory Events
Session
| Time | Event/Topic |
|---|---|
| 7:00 AM - 7:10 AM | DRIVE 2.0: Walking the Path for UTOPIA: Addressing Cancer Clinical Trial Excellence – Ruemu Birhiray, MD |
| 7:10 AM - 7:25 AM | Dismantling Structures of Injustice in Clinical Trial Participation: Duffy Null Phenotype and Ranking Trial Generalizability – Andrew Hantel, MD |
| 7:25 AM - 7:40 AM | Rank Score: Practical Applications and Utility of the DRIVE Rank Calculator in Clinical Trial Development – Maya Birhiray, MS, BS and Samuel Ranger, MS, BS |
| 7:40 AM - 7:55 AM | How Trial Diversity Matters: Discovering and Applying Race as Factor in Breast Cancer Management - Bryan Schneider, MD |
| 7:55 AM - 8:10 AM | How We Do It: Generating and Executing an Individual Plan to Achieve Clinical Excellence in Trials – Karen Winkfield, MD, PhD |
| 8:10 AM - 8:25 AM | Q/A and PANEL DISCUSSION & Break |
| 8:25 AM - 8:40 AM | Biology is Not Black or White: Recognizing, and Addressing Clinical Trial Representativeness to Achieve Clinical Trial Excellence – Matthew Lunning, DO, FACP |
| 8:40 AM - 8:55 AM | Do Not Cut and Paste: Improving Clinical Trial Representation with Biologically Determined Eligibility Criteria – Christopher Flowers, MD, MS, FASCO |
| 8:55 AM - 9:10 AM | Q/A and PANEL DISCUSSION & Break |
| 9:10 AM - 9:30 AM | Improvements in the Translation of Statistics, Thereby Achieving Increased Clinical Trial Participation – Bruce Craig, PhD |
| 9:30 AM - 9:50 AM | Our Common Alliance with the US FDA to Achieve Clinical Trial Excellence in Cancer Studies – |
| 9:50 AM - 10:10 AM | Next Steps: Leveraging ASCO for Representative Clinical Trial Research in Oncology - Carmen Guerra, MD, MSCE, FACP |
| 10:10 AM - 10:30 AM | Vox Medica: The Utility of Data Transparency of Trial Results in Medical Journals for the Clinician - Chadi Nabhan, MD, MBA, FACP |
| 10:30 AM - 10:45 AM | Walking Across the Aisle: Why and How PHARMA can Promote increased Clinical Trial Representativeness - Shalini Hede, PharmD |
| 10:45 AM - 11:00 AM | Advancing Representation in Oncology: Statistical Approaches to Ensure Diversity in Clinical Research - Joseph Unger, PhD, MS |
| 11:00 AM - 11:15 AM | Q/A AND PANEL DISCUSSION & Break |
| 11:15 AM - 11:35 AM | Molecular Diagnostics and the Future of Cancer Care - George Sledge Jr., MD |
| 11:35 AM - 11:50 AM | Patient-Centered Approaches to Engage Communities: Rural Populations - Electra Paskett, PhD, FACE |
| 11:50 AM - 12:10 PM | Medical Education as a Tool to Increase Representativeness in Clinical Research - Sasha Sharp, PhD |
| 12:10 PM - 12:25 PM | Q/A AND PANEL DISCUSSION & Break |
| 12:25 PM - 12:55 PM | Open Discussion on Strategies Moving Forwards |
| 12:55 PM - 1:00 PM | Closing Remarks and Thank You – Ruemu Birhiray, MD |
| 1:00 PM | Luncheon |